Director Daniel M. Junius filed a Form 144 notice of proposed sale of 500 shares of IDEXX Laboratories Inc common stock through a Fidelity Brokerage Services LLC account, with the notice dated November 4, 2026.

Key Highlights

  • Seller: Daniel M. Junius, identified in the filing as a Director of IDEXX Laboratories Inc /DE.
  • Shares proposed for sale: 500 shares of common stock, with an aggregate market value of $345,835.00 according to the filing.
  • Approximate sale date: November 4, 2026, through Fidelity Brokerage Services LLC, 245 Summer Street, Boston, MA 02110.
  • Original acquisition: The 500 shares were acquired via open market purchase on August 3, 2015, with payment made by check/cash on the same date.
  • Account type: The filing notes in the remarks section that the sale is "Selling out of his IRA."
  • Prior three-month sales: The filing reports nothing to report for securities sold during the past three months.
  • Shares outstanding: The filing lists 78,786,265 shares of common stock outstanding.

IDEXX Laboratories Director Files Rule 144 Notice for 500-Share IRA Sale

According to the Form 144 filing dated November 4, 2026, Daniel M. Junius, a Director of IDEXX Laboratories Inc /DE (NASDAQ:IDXX), provided notice of a proposed sale of 500 shares of the company's common stock. The filing identifies the broker as Fidelity Brokerage Services LLC, located at 245 Summer Street, Boston, MA 02110, and lists the approximate date of sale as November 4, 2026.

The filing discloses that the 500 shares subject to the proposed sale were originally acquired through an open market purchase on August 3, 2015, with full payment made by check or cash on that date. The aggregate market value of the shares proposed to be sold is listed as $345,835.00. The filing includes a remark stating that the director is "Selling out of his IRA," indicating the shares are held in an individual retirement account. The total shares of common stock outstanding are reported as 78,786,265.

The filing states that no securities of the issuer were sold by the reporting person during the three months preceding the notice. The notice was signed by Cristina Garcia as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Daniel M. Junius. By signing, the filing indicates the seller represents that he "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed."

What Was Disclosed

A Form 144 notice was filed on November 4, 2026, disclosing a proposed sale of 500 shares of IDEXX Laboratories Inc common stock by Director Daniel M. Junius from an IRA account, with an aggregate market value of $345,835.00, through Fidelity Brokerage Services LLC.